Thus, we evaluated the in vivo effects of RI-962 in two animal models of inflammatory diseases: TNFα-induced systemic inflammatory response syndrome (SIRS) and dextran sulfate sodium (DSS)-induced inflammatory bowel disease (IBD). The gene discussed is TNF; the disease is systemic inflammatory response syndrome.